肾盂输尿管癌（Upper Tract Urothelial Carcinoma, UTUC）是一种罕见的泌尿系统恶性肿瘤，起源于肾盂或输尿管的上皮细胞，多数患者以肾积水或无痛肉眼血尿就诊， 早期肿瘤影像学检查很难发现，容易与结石、炎症等疾病混淆。

在每年的国际罕见病日，我们都会聚焦那些鲜为人知却威胁健康的疾病。今天，我们要探讨的是一种罕见但极具侵略性的泌尿系统恶性肿瘤——肾盂输尿管癌（Upper Tract Urothelial Carcinoma, UTUC）。这种疾病起源于肾盂或输尿管的上皮细胞，多数患者以肾积水或无痛肉眼血尿就诊，早期影像学检查难以发现，容易与结石、炎症等混淆。

While randomized comparative trials are needed, a relatively new treatment option for upper urinary tract cancers shows ...

A recent study revealed a direct correlation between cumulative smoking exposure (CSE) and poorer oncologic outcomes in ...

Patients with low-grade upper tract urothelial carcinoma receiving primary treatment with 6 once-weekly pyelocalyceal doses ...

UroGen Pharma has reported the outcomes from a long-term follow-up study of JELMYTO (mitomycin) for pyelocalyceal solution for treating low-grade, upper tract urothelial cancer (LG-UTUC ...

The combination of Padcev and Keytruda showed promising clinical activity in UTUC patients, with a 25% ORR in primary lesions and 35% in target lesions. The study included 22 patients with intact ...

Of these, 22 (18.3%) had locally advanced UC and 98 (81.7%) had metastatic UC: 62 (51.6%) with lower tract UC (LUTC) and 36 (30%) with upper tract UC (UTUC). Patients had a median follow-up ...